Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05019716
Title Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Etoposide and Cisplatin) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Los Angeles General Medical Center RECRUITING Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
University of Pittsburgh Cancer Institute (UPCI) RECRUITING Pittsburgh Pennsylvania 15232 United States Details
M D Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field